menu search

Cellectis Announces Closing of Global Offering and Exercise of Underwriters’ Option to Purchase Additional Shares

Cellectis Announces Closing of Global Offering and Exercise of Underwriters’ Option to Purchase Additional Shares
NEW YORK, Feb. 07, 2023 (GLOBE NEWSWIRE) — Cellectis S.A. (“Cellectis” or the “Company”) (Euronext Growth: ALCLS – NASDAQ: CLLS), a clinical-stage biotechnology company using its pioneering gene-editing platform to develop life-saving cell and gene therapies, announced today: the initial closing on February 7, 2023 of the previously announced underwritten global offering by way of […] The post Cellectis Announces Closing of Global Offering and Exercise of Underwriters’ Option to Purchase Additio... Read More
Posted: Feb 8 2023, 00:01
Author Name: forextv
Views: 111718

Search within

Pages Search Results: